Page 3 - Nasdaq Repl News Today

Replimune Group (NASDAQ:REPL – Free Report) had its price target reduced by HC Wainwright from $51.00 to $50.00 in a report published on Monday, MarketBeat.com reports. They currently have a buy rating on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]

HC Wainwright reiterated their buy rating on shares of Replimune Group (NASDAQ:REPL – Free Report) in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a $51.00 target price on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]

Replimune Group (NASDAQ:REPL – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.75) EPS for the quarter, topping analysts’ consensus estimates of ($0.80) by $0.05, Briefing.com reports. During the same period in the prior year, the firm earned ($0.78) earnings per share. Replimune Group Stock Up 2.8 % REPL stock […]

Replimune Group (NASDAQ:REPL – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.75) EPS for the quarter, beating analysts’ consensus estimates of ($0.80) by $0.05, Briefing.com reports. During the same period last year, the business earned ($0.78) earnings per share. Replimune Group Price Performance NASDAQ REPL traded up $0.54 during […]

Emerald Advisers LLC cut its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 18.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 963,041 shares of the company’s stock after selling 223,000 shares during the period. Emerald Advisers LLC […]

Emerald Mutual Fund Advisers Trust lessened its position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 16.8% during the 1st quarter, Holdings Channel reports. The firm owned 803,448 shares of the company’s stock after selling 162,490 shares during the quarter. Emerald Mutual Fund Advisers Trust’s holdings in Replimune Group were worth $14,189,000 at the […]

Replimune Group (NASDAQ:REPL – Get Rating) had its price target raised by HC Wainwright from $50.00 to $51.00 in a research report released on Monday, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at ($0.88) EPS, Q4 […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Wedbush cut their FY2024 earnings per share estimates for shares of Replimune Group in a research note issued to investors on Monday, May 22nd. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($3.95) per share for the year, down from their previous […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) has received an average rating of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued ratings on the stock in the […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Investment analysts at Wedbush issued their Q1 2024 earnings estimates for shares of Replimune Group in a research report issued on Monday, May 22nd. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.87) per share for the quarter. The consensus estimate for Replimune […]